Discussing Breast Cancer ASCO 2022 Practice changing studies with Dr. Sara Tolaney, Chief – Division of Breast Oncology at Dana-Farber and Associate Professor at Harvard Medical School. Tags: Dr. Sara Tolaney Breast Cancer ASCO 2022 Share this: Related posts Conferences GU ASCO 2025 2025 GU ASCO 2025 Highlights - TALAPRO-2, NIAGARA, CheckMate-9ER, TiNivo-2 Mar 03, 2025 Conferences GI ASCO 2025 2025 GI ASCO 2025 Highlights - BREAKWATER, CheckMate-8HW, ALASCCA, STARTER-NET Feb 03, 2025 You might be interested in ASH Lymphoma 2024 Highlights - POLARIX Update, inMIND, TRIANGLE, ENRICH with Dr. Pallawi Torka Jan 21, 2025 SABCS 2024 Highlights - DESTINY-Breast06, DESTINY-Breast12, PATINA with Dr. Sara Tolaney Jan 17, 2025
Conferences GU ASCO 2025 2025 GU ASCO 2025 Highlights - TALAPRO-2, NIAGARA, CheckMate-9ER, TiNivo-2 Mar 03, 2025
Conferences GI ASCO 2025 2025 GI ASCO 2025 Highlights - BREAKWATER, CheckMate-8HW, ALASCCA, STARTER-NET Feb 03, 2025